“…Galectin-3 (Gal-3) is a 31 kDa β-galactoside-binding lectin that is immunohistochemically expressed in macrophages, lymphocytes, and endothelial cells, and in numerous types of cancer cells [1,2]. The expression of Gal-3 has been considered as a potential diagnostic and/or prognostic marker in stomach, colon-rectum, parathyroid, thyroid, breast, salivary glands, bladder, head and neck, prostate, and liver cancers [3,4,5,6,7,8].…”